Allergan

Omeros appoints Mitro as vice president, sales and marketing

Tuesday, December 4, 2012 08:00 AM

Omeros, a Seattle, Wash.-based clinical-stage biopharmaceutical company focused on products targeting inflammation, coagulopathies and disorders of the central nervous system, has appointed Thomas A. Mitro as vice president of sales and marketing.

More... »

Allergan to acquire SkinMedica for $350M

Monday, November 19, 2012 09:22 AM

Allergan, a multi-specialty health care company, has entered into a definitive agreement to acquire SkinMedica, a privately held,  topical aesthetics skin care business.

More... »

Aclaris raises $21M in Series A Financing

Thursday, October 25, 2012 07:30 AM

Aclaris Therapeutics, a privately held specialty pharmaceutical company focused on dermatological therapeutics, has secured $21 million in Series A financing.

More... »

Allergan opens NJ facility

Tuesday, September 4, 2012 12:39 PM

Irvine, Calif.-based Allergan has opened its first large facility in New Jersey, the R&D Center in Bridgewater, N.J.

More... »

Allergan, Molecular Partners form two exclusive alliances in eye disease

Tuesday, August 21, 2012 10:24 AM

Allergan, a multi-specialty health care company based in Medford, Mass., and Molecular Partners, a privately-owned Swiss biotech focused on a class of biological drugs known as DARPins, have significantly expanded their existing relationship by entering into two separate agreements to discover, develop and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases.

More... »

Allergan and Molecular Partners enter into license agreement

Wednesday, May 4, 2011 12:29 PM

Allergan and Molecular Partners have entered into a license agreement for MP0112, a phase II proprietary therapeutic DARPin(r) protein targeting VEGF under investigation for the treatment of retinal diseases.

More... »

Astellas Pharma Europe appoints Ken Jones as president and CEO

Monday, April 11, 2011 12:34 PM

Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma, has appointed Ken Jones as its president and CEO.  Jones was formerly COO at Astellas Pharma Europe.

More... »

Acadia and Allergan collaboration continues

Thursday, April 7, 2011 11:40 AM

Acadia Pharmaceuticals, a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, announced that it has extended its drug discovery and development collaboration with Allergan. 

More... »

Allergen executive takes CEO reins at Hospira

Wednesday, March 9, 2011 01:49 PM

Hospira has named former Allergan President F. Michael Ball its new CEO. The specialty pharma's current chief and founder, Christopher Begley, will become executive chairman.

More... »